ByAbba’s Aces:
The last time I wrote about Abbott Laboratories (ABT) I stated, “Due to the bearish technicals, falling financial efficiency ratios, and reduced 2015 earnings estimates, I will not be adding to my position right here.” Since writing the article, the stock has increased 6.75% versus the 6.12% gain the S&P 500 (SPY) posted.